Johnson Health Tech Co., Ltd. (1736)
TWSE
128.00
-0.50 (-0.39%)
Closed
Aug 27, 2026
Day's Range
127.00129.50
52 wk Range
102.00187.00
Financial Statements - 1736 - Johnson Health Tech Co., Ltd.
Revenue
54.32B▲ 13.7%
Net Income
2.75B▲ 13.1%Net Margin 5.1%
EBITDA
6.02B▲ 8.5%
Free Cash Flow
798.25M▲ 144.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 54.32B | 47.78B | 38.06B | 33.61B | 30.77B | 28.36B |
| Cost of Goods | 26.85B | 23.50B | 19.64B | 19B | 16.87B | 14.96B |
| Gross Profit | 27.47B | 24.27B | 18.42B | 14.60B | 13.90B | 13.39B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 3.66B | 3.38B | 1.37B | -196.53M | 538.43M | 981.68M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 3.93B | 3.49B | 1.33B | 303.60M | 163.70M | 975.33M |
| Income Tax | 1.17B | 1.06B | 625.04M | 78.66M | 64.33M | 227.97M |
| Net Income | 2.75B | 2.43B | 709.43M | 224.94M | 99.36M | 747.35M |
| EPS Basic | 9.06 | 8.02 | 2.34 | 1.42 | 0.13 | 2.24 |
| EPS Diluted | 9.06 | 8.01 | 2.34 | 1.42 | 0.13 | 2.24 |
| Basic Shares Outstanding | 303.37M | 303.10M | 302.92M | 302.62M | 302.58M | 302.66M |
| Diluted Shares Outstanding | 303.37M | 303.10M | 302.92M | 302.62M | 302.58M | 302.66M |
| Ebit | 4.31B | 3.84B | 1.71B | 559.78M | 327.18M | 1.13B |
| Ebitda | 6.02B | 5.55B | 3.24B | 1.78B | 1.75B | 2.17B |
| Net Income Continuous Operations | 3.93B | 3.49B | 1.33B | 303.60M | 163.70M | 975.33M |
| Minority Interests | -617K | -473K | 391K | 204.08M | -61.22M | -68.06M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
